8A) Antenatal Care: Obstetric cholestasis Flashcards

1
Q

Incidence of OC

A

0.7% of pregnancies (1.2-1.5% of Indian/Pakistani population)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Incidence of pruritus in pregnancy

A

23%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How often to repeat LFTs if symptoms persist but bloods normal?

A

Every 1-2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When to check LFTs postnatal?

A

Defer at least 10 days (can usually be done at 6w PN check)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How often to repeat LFTs once OC diagnosis confirmed?

A

Weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Monitoring in labour

A

Continuous CTG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Risks of OC

A
  • ?Stillbirth
  • Preterm birth (mostly iatrogenic)
  • Increased passage of meconium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can outcome in OC be predicted?

A

Can’t be predicted by biochemical results, USS or CTG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When to deliver with OC?

A

Discussion re: IOL from 37 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Recurrence rate of OC

A

45-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment for OC

A

Topical emollients - safe but may not be effective.
Chlorphenamine - sedation but doesn’t affect pruritus.
URSO - improves pruritus and LFTs.
Vitamin K (5-10mg daily) if PT prolonged.

Not in use:
Colestyramine
SAME
Dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors of obstetric cholestasis

A
Multiple pregnancy
IVF
Older women
Hx of gallstones or hep C
Sisters of affected women
Oral progesterone for PTB prevention
Low selenium and vitamin D intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percentage of cases of OC can be explained by known genetic variation?

A

10-15% (mutations in bile acid receptor FXR or transport proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What percentage of women present after 30 weeks?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What percentage of women get jaundice?

A

<10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FHx present in what percentage

A

14%

17
Q

Gallstones found in what percentage

A

13%

18
Q

Suggested “cut off” as high risk OC and recommend delivery from 37 weeks

A

Bile acids > 40

19
Q

When to start URSO?

A

Only if bile acids are raised (not just if abnormal LFTs)

20
Q

What produces AST?

A

Also skeletal/cardiac muscle (as well as liver)

21
Q

Risk of stillbirth in OC

A

1.5%

22
Q

Percentage of women with stillbirths associated with OC who have other comorbidities

A

70%

23
Q

Second line treatment for OC

A

Rifampicin

24
Q

Future risks after OC

A

HPB disease and cancer.
Immune mediated disease.
Cardiovascular disease.
Metabolic disease in child.

25
Q

Conditions associated with anti-nuclear antibodies

A

PBC
PSC
Autoimmune hepatitis

26
Q

Condition associated with anti-mitochondrial antibodies

A

PBC

27
Q

Condition associated with pANCA

A

PSC

28
Q

Conditions associated with aSMA

A

PSC

Autoimmune hepatitis

29
Q

Other antibodies seen in autoimmune hepatitis

A

LKM1
Anti-soluble liver antigen
Anti-liver pancreas antibodies.